GFN2016: Research on electronic cigarettes in Poland

(14:28)

GFN2016: Perceptual and experiential factors in switching to e-cigarettes

(16:38)

GFN2016: Evidence, Accountability, Transparency - whose science counts?

(1:17:47)

GFN2016: Safety \u0026 toxicology of e-cigarettes

(21:10)

GFN2016: Compensatory puffing behaviours in e-cigarette users

(15:55)

GFN2016: E-cigarettes: Gateway or Roadblock to Cigarette Smoking?

(17:31)

GFN2016: Prices \u0026 e-cigarette demand in the EU

(14:19)

GFN2016: Tobacco Heating System (THS) 2.2 cardiovascular disease risk assessment

(17:38)

GFN2016: Asking the right questions about smoking and alternative nicotine delivery systems

(11:58)

GFN2016: The power of non-nicotine factors in the habitual use of nicotine products

(12:43)

GFN2016: Population impact of e-cigarettes: recent evidence from the UK

(12:8)

GFN2016: E- cigarettes and mental health

(4:10)

GFN 2016: The e-cigarette environment in Australia

(16:43)

GFN2016: The Pleasure Principle - David Dorn

(4:29)

GFN2016: Unacountable and non-transparent: is the FCTC a threat to public health?

(24:44)

GFN2016: Exhaled aerosol particles e-cigs \u0026 cigarettes

(13:27)

GFN2016: E-cigarettes health potential: current evidence and future areas of exploration

(19:17)

GFN2016: What would good regulation of e-cigarettes look like?

(21:29)

GFN2016: Population impacts of snus - tobacco initiation \u0026 cessation

(14:5)